Differences in Extracellular NAD<sup>+</sup> and NMN Metabolism on the Surface of Vascular Endothelial Cells

Differences in Extracellular NAD<sup>+</sup> and NMN Metabolism on the Surface of Vascular Endothelial Cells

The disruption of the metabolism of extracellular NAD<sup>+</sup> and NMN may affect related signaling cascades and pathologies, such as cardiovascular or respiratory system diseases. We aimed to study NAD<sup>+</sup> and NMN hydrolysis on surface endothelial cells of diverse...

Full description

Bibliographic Details
Main Authors:	Patrycja Jablonska, Paulina Mierzejewska, Marta Tomczyk, Patrycja Koszalka, Marika Franczak, Ada Kawecka, Barbara Kutryb-Zajac, Alicja Braczko, Ryszard T. Smolenski, Ewa M. Slominska
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biology
Subjects:	extracellular NAD<sup>+</sup> metabolism extracellular NMN metabolism vascular endothelial cells CD38 CD73
Online Access:	https://www.mdpi.com/2079-7737/11/5/675

Similar Items

Triple-Isotope Tracing for Pathway Discernment of NMN-Induced NAD<sup>+</sup> Biosynthesis in Whole Mice
by: Anthony A. Sauve, et al.
Published: (2023-07-01)

Regulation of Glucose Metabolism by NAD<sup>+</sup> and ADP-Ribosylation
by: Ann-Katrin Hopp, et al.
Published: (2019-08-01)

NAD<sup>+</sup> Anabolism Disturbance Causes Glomerular Mesangial Cell Injury in Diabetic Nephropathy
by: Xue Li, et al.
Published: (2022-03-01)

Nicotinamide Mononucleotide Supplementation Improves Mitochondrial Dysfunction and Rescues Cellular Senescence by NAD<sup>+</sup>/Sirt3 Pathway in Mesenchymal Stem Cells
by: Huan Wang, et al.
Published: (2022-11-01)

NAD<sup>+</sup> Metabolism and Regulation: Lessons From Yeast
by: Trevor Croft, et al.
Published: (2020-02-01)

Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer’s Disease
by: Weijia Wu, et al.
Published: (2023-06-01)

Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
by: Chidambaram Ramanathan, et al.
Published: (2022-01-01)

NAD<sup>+</sup> Metabolism and Diseases with Motor Dysfunction
by: Samuel Lundt, et al.
Published: (2021-11-01)

Senescent Tumor CD8<sup>+</sup> T Cells: Mechanisms of Induction and Challenges to Immunotherapy
by: Wei Liu, et al.
Published: (2020-09-01)

Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process
by: Fiqri D. Khaidizar, et al.
Published: (2021-04-01)

Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons
by: Krish Chandrasekaran, et al.
Published: (2020-05-01)

Role of PGC-1α in the Mitochondrial NAD<sup>+</sup> Pool in Metabolic Diseases
by: Jin-Ho Koh, et al.
Published: (2021-04-01)

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering Agents
by: Pamela Becherini, et al.
Published: (2023-02-01)

Inhibitors of NAD<sup>+</sup> Production in Cancer Treatment: State of the Art and Perspectives
by: Moustafa S. Ghanem, et al.
Published: (2024-02-01)

TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
by: Harshad S. Ugamraj, et al.
Published: (2022-12-01)

CD3<sup>+</sup>, CD8<sup>+</sup>, CD4<sup>+</sup> and FOXP3<sup>+</sup> T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
by: Niko Hiltunen, et al.
Published: (2021-06-01)

Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota
by: Pan Huang, et al.
Published: (2022-01-01)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
by: Lars Jansen Sverkeli, et al.
Published: (2021-07-01)

The Histone Deacetylases Hst1 and Rpd3 Integrate De Novo NAD<sup>+</sup> Metabolism with Phosphate Sensing in <i>Saccharomyces cerevisiae</i>
by: Benjamin Groth, et al.
Published: (2023-04-01)

CD38: T Cell Immuno-Metabolic Modulator
by: Anwesha Kar, et al.
Published: (2020-07-01)

Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
by: Flavia Ferrantelli, et al.
Published: (2021-05-01)

A Method to Monitor the NAD<sup>+</sup> Metabolome—From Mechanistic to Clinical Applications
by: Maria Pilar Giner, et al.
Published: (2021-09-01)

Effects of Chemotherapy on Hematological Parameters and CD4<sup>+</sup>/CD8<sup>+</sup> Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
by: Tassanee Jaroensong, et al.
Published: (2022-01-01)

N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2020-05-01)

The Effect of a Linear Tuning between the Antigenic Stimulations of CD4<sup>+</sup> T Cells and CD4<sup>+</sup> Tregs
by: Aliyu A. Yusuf, et al.
Published: (2020-02-01)

CD4<sup>+</sup>CD25<sup>+</sup> Cells Are Essential for Maintaining Immune Tolerance in Chickens Inoculated with Bovine Serum Albumin at the Late Stage of Embryonic Development
by: Xiaoxue Yu, et al.
Published: (2020-10-01)

Roles of NAD<sup>+</sup> and Its Metabolites Regulated Calcium Channels in Cancer
by: Peilin Yu, et al.
Published: (2020-10-01)

A Population of CD4<sup>+</sup>CD8<sup>+</sup> Double-Positive T Cells Associated with Risk of Plasma Leakage in Dengue Viral Infection
by: Esther Dawen Yu, et al.
Published: (2022-01-01)

NAD<sup>+</sup> Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
by: Lucie Chanvillard, et al.
Published: (2022-12-01)

Oclacitinib, a Janus Kinase Inhibitor, Reduces the Frequency of IL-4- and IL-10-, but Not IFN-γ-, Producing Murine CD4<sup>+</sup> and CD8<sup>+</sup> T Cells and Counteracts the Induction of Type 1 Regulatory T Cells
by: Agnieszka Jasiecka-Mikołajczyk, et al.
Published: (2021-09-01)

NADomics: Measuring NAD<sup>+</sup> and Related Metabolites Using Liquid Chromatography Mass Spectrometry
by: Nady Braidy, et al.
Published: (2021-05-01)

CD34<sup>+</sup>CD10<sup>+</sup>CD19<sup>−</sup> Cells in Patients with Unhealthy Alcohol Use Stimulate the M2b Monocyte Polarization
by: Akira Asai, et al.
Published: (2022-08-01)

Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD<sup>+</sup> Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells
by: Natalie Baum, et al.
Published: (2020-12-01)

In-vitro inhibition of IFNγ<sup>+</sup> iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function
by: Daniel Volker, et al.
Published: (2012-08-01)

The Role of NAD<sup>+</sup> and NAD<sup>+</sup>-Boosting Therapies in Inflammatory Response by IL-13
by: Anton D. Pugel, et al.
Published: (2024-02-01)

The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis
by: Ekaterina Podyacheva, et al.
Published: (2023-04-01)

NAD<sup>+</sup> Precursors: A Questionable Redundancy
by: Carles Canto
Published: (2022-07-01)

CD8<sup>+</sup> T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
by: Valentina Tedeschi, et al.
Published: (2022-03-01)

Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
by: Flavia Ferrantelli, et al.
Published: (2021-03-01)

Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4<sup>+</sup> T Cells—Implications for the Pathogenesis of Systemic Lupus Erythematosus
by: Joy S. Park, et al.
Published: (2023-06-01)